KLF1 and neoplasm: The decreased expression levels of WNT1, cytoplasmic and nuclear β-catenin, and downstream targets c-Myc and cyclin D1 suggest that KLF1 promotes the proliferation and EMT progression of tumor cells by activating this signaling pathway (57).